|
Oprah Wins, but Loopholes Remain
Press release: February 1998
The verdict is in - and Oprah Winfrey and activist Howard
Lyman have been found not guilty when a federal
jury ruled she did not slander the beef industry in a 1996
show on mad cow disease. But EarthSave International, a non-profit
educational group, remains concerned about the veggie
libel laws and loopholes in the FDAs mad
cow protection practices.
Free speech on trial
Since the judge ruled that the cattlemen didnt have
a case under the food disparagement laws, the
attention has turned away from whether or not these laws are
unconstitutional. In typical libel cases, the burden of proof
is on the plaintiff. But with food disparagement laws the
burden is on the defense.
We need to keep our attention on the veggie libel
laws says EarthSave President Stacey Vicari. The
verdict is great. But people might forget that these laws
could make consumers and educational groups afraid to engage
in healthy debate about important topics.
"Mad Cow" loopholes
EarthSave is also concerned that current FDA rules leave
dangerous loopholes in our protection from diseases like mad
cow. During the infamous Oprah episode, ex-cattle rancher
Howard Lyman exposed the widespread practice of feeding animals
to other animals. This revelation shocked Winfrey and millions
of Americans.
Last summer the FDA prohibited livestock producers from feeding
cow remains back to cows, eight years after a similar ban
was instituted in great Britain where scientists now believe
that mad cow disease is responsible for some 20 deaths in
humans. But the agency allowed the remains of pigs, horses
and chickens (as well as blood and gelatin from any animal)
to be used in animal feed. The rulings also allow animals
known to have TSE diseases (such as sheep with scrapie) to
be fed to pigs, fed to chickens, even turned into pet food.
EarthSave feels that the FDA ban may leave the door open
to risk unless we ban the feeding of all animal parts to other
animals being raised for human consumption. This has been
done in other countries and the FDA should follow their lead.
|